The novel immunotoxin HM1.24-ETA′ induces apoptosis in multiple myeloma cells

por Staudinger, M, Glorius, P, Burger, R, Kellner, C, Klausz, K, Günther, A, Repp, R, Klapper, W, Gramatzki, M, Peipp, M
Publicado 2014

IL-2 in combination with IFN-αand 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trial

por Atzpodien, J, Kirchner, H, Illiger, H J, Metzner, B, Ukena, D, Schott, H, Funke, P J, Gramatzki, M, Jürgenson, S von, Wandert, T, Patzelt, T, Reitz, M
Publicado 2001

Phase I clinical trial of the bispecific antibody MDX-H210 (anti-FcγRI × anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer

por Repp, R, van Ojik, H H, Valerius, T, Groenewegen, G, Wieland, G, Oetzel, C, Stockmeyer, B, Becker, W, Eisenhut, M, Steininger, H, Deo, Y M, Blijham, G H, Kalden, J R, van de Winkel, J G J, Gramatzki, M
Publicado 2003